Sultana Jahan, MD (@sultanajahanmd) 's Twitter Profile
Sultana Jahan, MD

@sultanajahanmd

Internal Medicine PGY-1 Resident @ValleyhealthLV |Cardiology 🫀 Aspirant
| Former clinical Research Trainee @BrighamWomens @HarvardMed

ID: 1575285801675546626

calendar_today29-09-2022 00:46:43

1,1K Tweet

595 Followers

1,1K Following

Dani Crousillat (@dcrousillat) 's Twitter Profile Photo

🌟 Now Accepting Applications!! Advanced Fellowship in Women’s Heart & Cardio-Obstetrics USF Health Tampa General Hospital Application Deadline: Monday, September 15th, 2025 for AY 2026-2027 🔗 Learn more or apply today! Email: [email protected]

🌟 Now Accepting Applications!! 

Advanced Fellowship in Women’s Heart &amp; Cardio-Obstetrics <a href="/USFHealth/">USF Health</a> <a href="/TGHCares/">Tampa General Hospital</a> 

Application Deadline: Monday, September 15th, 2025 for AY 2026-2027

🔗 Learn more or apply today! Email: crousillatd@usf.edu
Sultana Jahan, MD (@sultanajahanmd) 's Twitter Profile Photo

Had a great time at #CVI2025 beyond learning about the latest innovations in cardiology, It was amazing to explore Austin and reconnect with all. ❤️❤️ Mustafa Turkmani Rajendra P Shah 🫀

Had a great time at #CVI2025 beyond learning about the latest innovations in cardiology, 
It was amazing to explore Austin and reconnect with all. ❤️❤️ <a href="/DrMustafaT/">Mustafa Turkmani</a> <a href="/RajendraPShahMD/">Rajendra P Shah 🫀</a>
Sultana Jahan, MD (@sultanajahanmd) 's Twitter Profile Photo

Such a great pleasure catching up with Dr. Timir Paul, MD, PhD, FACC, FSCAI, FAHA and his incredible kids — future interventional cardiologists in the making! Truly inspiring to see the next generation already so passionate. 🫀✨#MedTwitter #CVI2025 #FutureDocs CV Innovations Emmanouil Brilakis Mehdi Shishehbor, DO Paul

Such a great pleasure catching up with Dr. <a href="/timir_paul/">Timir Paul, MD, PhD, FACC, FSCAI, FAHA</a> and his incredible kids — future interventional cardiologists in the making! Truly inspiring to see the next generation already so passionate. 🫀✨#MedTwitter #CVI2025 #FutureDocs
<a href="/cvinnovations/">CV Innovations</a> <a href="/esbrilakis/">Emmanouil Brilakis</a> <a href="/shishem/">Mehdi Shishehbor, DO</a> <a href="/psorajja/">Paul</a>
Monika Sanghavi MD, FACC (@monsangh) 's Twitter Profile Photo

Excited to present for our community “The Pregnancy-Heart Connection: What We Can Learn and Why It Matters for South Asian Women”

Ankeet S. Bhatt, MD, MBA (@ankeetbhatt) 's Twitter Profile Photo

#HFimpEF is common, but data are limited on #GDMT & outcomes. In JACC Journals, the largest look at HFimpEF in US to date. 🎯>28K new HFrEF pts, 1 in 3 improved to HFimpEF. 🎯 GDMT ⤵️ after HFimpEF. 🎯 Many pts remained at ⏫ risk. 💡 Tailored trials & #ImpSci strategies needed.

#HFimpEF is common, but data are limited on #GDMT &amp; outcomes. In <a href="/JACCJournals/">JACC Journals</a>, the largest look at HFimpEF in US to date.
🎯&gt;28K new HFrEF pts, 1 in 3 improved to HFimpEF.
🎯 GDMT ⤵️ after HFimpEF.
🎯 Many pts remained at ⏫ risk.

💡 Tailored trials &amp; #ImpSci strategies needed.
Rahul Aggarwal (@rahulaggarwalmd) 's Twitter Profile Photo

Asian Indian, Chinese, and Filipino Americans have high mortality rates from cardiovascular conditions. Our new @AnnalsIM study presents nationally representative data. Prevention strategies are needed. acpjournals.org/doi/10.7326/AN… Dr. Deepak L. Bhatt, Rishi Wadhera, MD MPP, Nicholas Chiu, MD MPH

Asian Indian, Chinese, and Filipino Americans have high mortality rates from cardiovascular conditions.

Our new @AnnalsIM study presents nationally representative data.  Prevention strategies are needed. 

acpjournals.org/doi/10.7326/AN…

<a href="/DLBHATTMD/">Dr. Deepak L. Bhatt</a>, <a href="/rkwadhera/">Rishi Wadhera, MD MPP</a>, <a href="/NicholasChiuMD/">Nicholas Chiu, MD MPH</a>
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

Wow, the game has changed! #SURPASSCVOT meets its primary & secondary endpoints in first *head-to-head* CV outcomes trial! Tirzepatide (dual GLP1/GIP agonist) vs Dulaglutide (GLP-1RA) including 16% lower risk of all cause mortality! investor.lilly.com/news-releases/…

Wow, the game has changed! #SURPASSCVOT meets its primary &amp; secondary endpoints in first *head-to-head* CV outcomes trial!

Tirzepatide (dual GLP1/GIP agonist) vs Dulaglutide (GLP-1RA)

including 16% lower risk of all cause mortality!

investor.lilly.com/news-releases/…
Yara Jelwan (@yjelwan) 's Twitter Profile Photo

Risk assessment is 🔑 to identifying LDL goals. Dr Ty Gluckman presented an overview of current national cholesterol guidelines at #ASPC2025 Training Academy 🫀 ASPC #FacesofCVPrevention

Risk assessment is 🔑 to identifying LDL goals. Dr <a href="/tygluckman/">Ty Gluckman</a> presented an overview of current national cholesterol guidelines at #ASPC2025 Training Academy
🫀
<a href="/ASPCardio/">ASPC</a> 
#FacesofCVPrevention
Yara Jelwan (@yjelwan) 's Twitter Profile Photo

Inflammation is a 🔑 driver of atherosclerosis, independent of cholesterol. Dr Fatima Rodriguez summarized what we know about inflammation and ASCVD 🫀 #ASPC2025 ASPC #FacesofCVPrevention

Inflammation is a 🔑 driver of atherosclerosis, independent of cholesterol. 
Dr <a href="/FaRodriguezMD/">Fatima Rodriguez</a> summarized what we know about inflammation and ASCVD 🫀 

#ASPC2025 <a href="/ASPCardio/">ASPC</a> 
#FacesofCVPrevention
Yara Jelwan (@yjelwan) 's Twitter Profile Photo

When it comes to CAC, #keepitsimple Know when to use #PowerofZero to identify very low risk groups and help focus rx on those who need it most. Dr Khurram Nasir helped summarize CAC testing from theory to practice #ASPC2025 ASPC Michael J. Blaha Roger Blumenthal Johns Hopkins Ciccarone Center

When it comes to CAC, #keepitsimple

Know when to use #PowerofZero to identify very low risk groups and help focus rx on those who need it most. 

Dr <a href="/khurramn1/">Khurram Nasir</a> helped summarize CAC testing from theory to practice

#ASPC2025 <a href="/ASPCardio/">ASPC</a> <a href="/MichaelJBlaha/">Michael J. Blaha</a> <a href="/rblument1/">Roger Blumenthal</a> <a href="/CiccaroneCenter/">Johns Hopkins Ciccarone Center</a>
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Dr. Gulati and I delve into the SURPASS-CVOT trial, examining whether dual agonism provides superior efficacy over GLP-1 monotherapy, and discuss what this means for the future of obesity research.

Sultana Jahan, MD (@sultanajahanmd) 's Twitter Profile Photo

Such an insightful and inspiring conversation for IMGs aspiring to become cardiologists and preparing for fellowship—thank you Saurabh S Dani, MD, MSc and Krutarth Pandya for sharing this! As an IMG on this path myself, it deeply resonated with me 🙏🫀 #CardioFellowship Lahey Cardiology

Yara Jelwan (@yjelwan) 's Twitter Profile Photo

Dr Ron Blankstein makes the case for linking preventive cardiology and cardiac imaging in your career. The best of both worlds 🫀🤌🏻 : imaging ➡️ convey info to patient that is informative, motivating and actionable #ASPC2025 ASPC Heart_SCCT

Dr <a href="/RonBlankstein/">Ron Blankstein</a> makes the case for linking preventive cardiology and cardiac imaging in your career. 

The best of both worlds 🫀🤌🏻  : imaging ➡️ convey info to patient that is informative, motivating and actionable 

#ASPC2025 <a href="/ASPCardio/">ASPC</a> <a href="/Heart_SCCT/">Heart_SCCT</a>
CardioVisual: Powered by MedicalVisual (@cardiovisualapp) 's Twitter Profile Photo

At ASPC 2025, Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 talks about risk scores being inadequate for young women Pregnancy history & nontraditional risk factors matter Full interview coming soon. #ASPC2025 #CardioTwitter #WomenHeartHealth

CardioVisual: Powered by MedicalVisual (@cardiovisualapp) 's Twitter Profile Photo

At ASPC 2025, Dr. Deepak Bhatt Dr. Deepak L. Bhatt spoke on how renal denervation is showing modest but durable benefit for select patients. Full interview coming soon. #ASPC2025 #CardioTwitter #RenalDenervation

CardioVisual: Powered by MedicalVisual (@cardiovisualapp) 's Twitter Profile Photo

At ASPC 2025, Dr. Khurram Nasir explained a paradox: Fewer deaths after heart disease, yet no drop in first-time heart attacks. Prevention must move upstream. Full interview coming soon. #ASPC2025 #CardioTwitter #PreventiveCardiology

Sultana Jahan, MD (@sultanajahanmd) 's Twitter Profile Photo

🚨 Thrilled to share that 2 of my abstracts have been accepted as Moderated Poster Presentations at #AHA25 in New Orleans, Louisiana! 🎉 Grateful to my mentors & collaborators for their support Saurabh S Dani, MD, MSc Sarju Ganatra, MD, FACC Jamal Rana, MD AHA Science Circulation ❤️‍🩹✨ #CardioTwitter

🚨 Thrilled to share that 2 of my abstracts have been accepted as Moderated Poster Presentations at #AHA25 in New Orleans, Louisiana! 🎉 Grateful to my mentors &amp; collaborators for their support <a href="/SaurabhSDani/">Saurabh S Dani, MD, MSc</a> <a href="/SarjuGanatraMD/">Sarju Ganatra, MD, FACC</a> <a href="/JamalRanaMD/">Jamal Rana, MD</a> <a href="/AHAScience/">AHA Science</a>  <a href="/CircAHA/">Circulation</a> ❤️‍🩹✨ #CardioTwitter